Your browser doesn't support javascript.
loading
Inhibition of the Cell Uptake of Delta and Omicron SARS-CoV-2 Pseudoviruses by N-Acetylcysteine Irrespective of the Oxidoreductive Environment.
La Maestra, Sebastiano; Garibaldi, Silvano; Balansky, Roumen; D'Agostini, Francesco; Micale, Rosanna T; De Flora, Silvio.
Afiliación
  • La Maestra S; Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy.
  • Garibaldi S; Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, 16132 Genoa, Italy.
  • Balansky R; National Centre of Oncology, 1756 Sofia, Bulgaria.
  • D'Agostini F; Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy.
  • Micale RT; Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy.
  • De Flora S; Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy.
Cells ; 11(20)2022 10 21.
Article en En | MEDLINE | ID: mdl-36291178
ABSTRACT
The binding of SARS-CoV-2 spikes to the cell receptor angiotensin-converting enzyme 2 (ACE2) is a crucial target both in the prevention and in the therapy of COVID-19. We explored the involvement of oxidoreductive mechanisms by investigating the effects of oxidants and antioxidants on virus uptake by ACE2-expressing cells of human origin (ACE2-HEK293). The cell uptake of pseudoviruses carrying the envelope of either Delta or Omicron variants of SARS-CoV-2 was evaluated by means of a cytofluorimetric approach. The thiol N-acetyl-L-cysteine (NAC) inhibited the uptake of both variants in a reproducible and dose-dependent fashion. Ascorbic acid showed modest effects. In contrast, neither hydrogen peroxide (H2O2) nor a system-generating reactive oxygen species (ROS), which play an important role in the intracellular alterations produced by SARS-CoV-2, were able to affect the ability of either Delta or Omicron SARS-CoV-2 pseudoviruses to be internalized into ACE2-expressing cells. In addition, neither H2O2 nor the ROS generating system interfered with the ability of NAC to inhibit that mechanism. Moreover, based on previous studies, a preventive pharmacological approach with NAC would have the advantage of decreasing the risk of developing COVID-19, irrespective of its variants, and at the same time other respiratory viral infections and associated comorbidities.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enzima Convertidora de Angiotensina 2 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enzima Convertidora de Angiotensina 2 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: Italia